Myrthe J. van Dijk

Myrthe J. van Dijk

Auto-generated profile, based on publicly available information

Myrthe J. van Dijk

Department of Central Diagnostic Laboratory—Research, University Medical Center Utrecht Utrecht University Utrecht The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2022 in American Journal of Hematology
Verified
Journal Article
Closed access
MDMyrthe J. van Dijk
Myrthe J. van Dijk
MRMinke A.E. Rab
Minke A.E. Rab
BOBrigitte A. van Oirschot
Brigitte A. van Oirschot
JBJennifer Bos
Jennifer Bos
CDCleo Derichs
Cleo Derichs
EBEduard J. van Beers
Eduard J. van Beers

6 September 2023 in American Journal of Hematology
Verified
Journal Article
Open access
MDMyrthe J. van Dijk
Myrthe J. van Dijk
BOBrigitte A. van Oirschot
Brigitte A. van Oirschot
AHAlexander N. Harrison
Alexander N. Harrison
SRSteffen Michael Recktenwald
Steffen Michael Recktenwald
MQMin Qiao
Min Qiao
RWRichard van Wijk
Richard van Wijk
Adenosine Triphosphatase (ATPase) Phospholipid Transporting 11C gene (ATP11C) encodes the major phosphatidylserine (PS) flippase in human red blood cells (RBCs). Flippases actively transport phospholipids (e.g., PS) from the outer to the inner leaflet to establish and maintain phospholipid asymmetry of the lipid bilayer of cell membranes. This asymmetry is crucial for survival since externalized PS triggers phagocytosis by splenic macrophages. Here we report on pathophysiological consequences of decreased flippase activity, prompted by a patient with hemolytic anemia and hemizygosity for a novel c.2365C > T p.(Leu789Phe) missense variant in ATP11C. ATP11C protein expression was strongly reduced by 58% in patient‐derived RBC ghosts. Furthermore, functional characterization showed only 26% PS flippase activity. These results were confirmed by recombinant mutant ATP11C protein expression in HEK293T cells, which was decreased to 27% compared to wild type, whereas PS‐stimulated ATPase activity was decreased by 57%. Patient RBCs showed a mild increase in PS surface exposure when compared to control RBCs, which further increased in the most dense RBCs after RBC storage stress. The increase in PS was not due to higher global membrane content of PS or other phospholipids. In contrast, membrane lipid lateral distribution showed increased abundance of cholesterol‐enriched domains in RBC low curvature areas. Finally, more dense RBCs and subtle changes in RBC morphology under flow hint toward alterations in flow behavior of ATP11C‐deficient RBCs. Altogether, ATP11C deficiency is the likely cause of hemolytic anemia in our patient, thereby underlining the physiological role and relevance of this flippase in human RBCs.

21 February 2025 in American Journal of Hematology
Verified
Journal Article
Open access
MTM. J. M. Traets
M. J. M. Traets
JBJ. F. Bos
J. F. Bos
SVS. van der Veen
S. van der Veen
LPL. van Pelt
L. van Pelt
MDM. J. van Dijk
M. J. van Dijk
MRMinke A.E. Rab
Minke A.E. Rab
Pyruvate kinase (PK) is a key enzyme involved in the final step of glycolysis, essential to produce adenosine triphosphate (ATP). Relatively decreased red blood cell (RBC) PK activity (reflected by a lower PK/hexokinase [HK] ratio) and PK thermostability (PK activity after exposure to heat) were recently identified as pathophysiological features of sickle cell disease (SCD). In this study, we investigated whether impaired PK function is associated with sickle RBC properties and SCD‐related clinical manifestations. This study included 97 non‐transfused patients with SCD (88 HbSS, 9 HbS/β0 thalassemia). PK thermostability was correlated with RBC parameters such as reticulocyte count (r = −0.402, p < 0.0001) and hemoglobin F (r = 0.394, p < 0.0001), and indicators of impaired functional properties of sickle RBCs, such as the point of sickling (r = −0.417, p < 0.0001), oxygen affinity (r = 0.408, p < 0.001) and RBC adhesion to laminin (r = −0.322, p = 0.024). Additionally, a low PK/HK ratio correlated with decreased PK thermostability (r = 0.308, p = 0.002), decreased RBC deformability (r = 0.268, p = 0.009), and elevated 2,3‐diphosphoglycerate levels (r = −0.244, p = 0.016). Multivariate Poisson regression analysis demonstrated that reduced PK thermostability and PK/HK ratio were associated with a higher incidence of SCD‐related clinical complications. For every 10‐unit decrease in PK thermostability and 1‐unit decrease in PK/HK ratio, the incidence of SCD‐related clinical complications increased by 11% (p = 0.012) and 10% (p = 0.019), respectively. Altogether, these findings indicate that impaired PK function is related to compromised sickle RBC properties and SCD‐related clinical manifestations. This supports the relevance and underlines the potential of PK activation therapy.

30 September 2022 in British Journal of Haematology
Verified
Journal Article
Open access
MDMyrthe J. van Dijk
Myrthe J. van Dijk
BOBrigitte A. van Oirschot
Brigitte A. van Oirschot
MSManon C. Stam‐Slob
Manon C. Stam‐Slob
EWEsmé Waanders
Esmé Waanders
BZBert van der Zwaag
Bert van der Zwaag
RWRichard van Wijk
Richard van Wijk
Summary: Erythrocytosis is associated with increased red blood cell mass and can be either congenital or acquired. Congenital secondary causes are rare and include germline variants increasing haemoglobin (Hb)‐oxygen affinity (e.g., Hb or bisphosphoglycerate mutase (BPGM) variants) or affecting oxygen‐sensing pathway proteins. Here, we describe five adults from three kindreds with erythrocytosis associated with heterozygosity for BPGM variants, including one novel. Functional analyses showed partial BPGM deficiency, reduced 2,3‐bisphosphoglycerate levels and/or increased Hb‐oxygen affinity. We also review currently known BPGM variants. This study contributes to raising awareness of BPGM variants, and in particular that heterozygosity for BPGM deficiency may already manifest clinically.

2 February 2024 in eJHaem
Verified
Journal Article
Open access
MDMyrthe J. van Dijk
Myrthe J. van Dijk
MTMarissa J. M. Traets
Marissa J. M. Traets
BOBrigitte A. van Oirschot
Brigitte A. van Oirschot
TRTitine J. J. Ruiter
Titine J. J. Ruiter
JWJonathan R. A. de Wilde
Jonathan R. A. de Wilde
MRMinke A.E. Rab
Minke A.E. Rab
The most common forms of sickle cell disease (SCD) are sickle cell anemia (SCA; HbSS) and HbSC disease. In both, especially the more dense, dehydrated and adherent red blood cells (RBCs) with reduced deformability are prone to hemolysis and sickling, and thereby vaso‐occlusion. Based on plasma amino acid profiling in SCD, a composition of 10 amino acids and derivatives (RCitNacQCarLKHVS; Axcella Therapeutics, USA), referred to as endogenous metabolic modulators (EMMs), was designed to target RBC metabolism. The effects of ex vivo treatment with the EMM composition on different RBC properties were studied in SCD (n = 9 SCA, n = 5 HbSC disease). Dose‐dependent improvements were observed in RBC hydration assessed by hemocytometry (MCV, MCHC, dense RBCs) and osmotic gradient ektacytometry (Ohyper). Median (interquartile range [IQR]) increase in Ohyper compared to vehicle was 4.9% (4.0%–5.5%), 7.5% (6.9%–9.4%), and 12.8% (11.5%–14.0%) with increasing 20×, 40×, and 80X concentrations, respectively (all p < 0.0001). RBC deformability (EImax using oxygen gradient ektacytometry) increased by 8.1% (2.2%–12.1%; p = 0.0012), 9.6% (2.9%–15.1%; p = 0.0013), and 13.3% (5.7%–25.5%; p = 0.0007), respectively. Besides, RBC adhesion to subendothelial laminin decreased by 43% (6%–68%; p = 0.4324), 58% (48%–72%; p = 0.0185), and 71% (49%–82%; p = 0.0016), respectively. Together, these results provide a rationale for further studies with the EMM composition targeting multiple RBC properties in SCD.